4-methyl-1-[2-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoyl]piperidine
Structure Info
- Chemspace ID
- CSSB02533253564 (In-Stock Building Blocks)
- IUPAC Name
- 4-methyl-1-[2-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoyl]piperidine
- Mol formula
- C20H30BNO3
- Mol weight
- 343 Da
- Catalog Number(s)
- BBLS02533253564, BBV-331915483, EN300-55408782, bbls02533253564
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- 4.56
- Heavy atoms count
- 25
- Rotatable bond count
- 2
- Number of rings
- 3
- Carbon bond saturation, Fsp3
- 0.65
- Polar surface area (Å)
- 39
- Hydrogen bond acceptors count
- 3
- Hydrogen bond donors count
- 0
![Chemical structure of 4-methyl-1-[2-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoyl]piperidine (C20H30BNO3) - CSSB02533253564](/st/structure/200/a0db2d14e0729f7bcc3eb9cf3c832949/CC1CCN%2528CC1%2529C%2528%253DO%2529C1%253DCC%2528%253DCC%253DC1C%2529B1OC%2528C%2529%2528C%2529C%2528C%2529%2528C%2529O1.png "C20H30BNO3")
- Zoom the structure
- CSSB02533253564
Items Overall 8 items from 1 supplier
| Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
|---|---|---|---|---|---|---|
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 50 mg | 360.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 100 mg | 376.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 250 mg | 393.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 500 mg | 410.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 1 g | 427.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 2.5 g | 838.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 5 g | 1,240.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 10 g | 1,839.00 |
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire
Similarity Analogs
![Chemical structure of 3-methyl-1-[2-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoyl]pyrrolidine - CSSB02526778984](/st/structure/200/6ec9913773d72c2129507653e589e6e6/CC1CCN%2528C1%2529C%2528%253DO%2529C1%253DCC%2528%253DCC%253DC1C%2529B1OC%2528C%2529%2528C%2529C%2528C%2529%2528C%2529O1.png)
![Chemical structure of 4-fluoro-1-[2-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoyl]piperidine - CSSB02533255706](/st/structure/200/096724d787ccfd78ca543a81b40e9482/CC1%253DCC%253DC%2528C%253DC1C%2528%253DO%2529N1CCC%2528F%2529CC1%2529B1OC%2528C%2529%2528C%2529C%2528C%2529%2528C%2529O1.png)
![Chemical structure of 3-methyl-1-[2-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoyl]piperidine - CSSB02533505523](/st/structure/200/ab7587f9b96a2d698c5cb69670866dd7/CC1CCCN%2528C1%2529C%2528%253DO%2529C1%253DCC%2528%253DCC%253DC1C%2529B1OC%2528C%2529%2528C%2529C%2528C%2529%2528C%2529O1.png)
![Chemical structure of (3S)-3-methyl-1-[2-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoyl]piperidine - CSSB02533260125](/st/structure/200/725b97802833f6ecf0db79a261999a39/C%255BC%2540H%255D1CCCN%2528C1%2529C%2528%253DO%2529C1%253DCC%2528%253DCC%253DC1C%2529B1OC%2528C%2529%2528C%2529C%2528C%2529%2528C%2529O1.png)
![Chemical structure of (3S)-3-fluoro-1-[2-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoyl]pyrrolidine - CSSB02526778521](/st/structure/200/c0deaef68f71c55fb08a978a16199414/CC1%253DCC%253DC%2528C%253DC1C%2528%253DO%2529N1CC%255BC%2540H%255D%2528F%2529C1%2529B1OC%2528C%2529%2528C%2529C%2528C%2529%2528C%2529O1.png)
![Chemical structure of 3-fluoro-1-[2-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoyl]pyrrolidine - CSSB02526924693](/st/structure/200/b44e39c17cb2784137085ec7a6b2f5d8/CC1%253DCC%253DC%2528C%253DC1C%2528%253DO%2529N1CCC%2528F%2529C1%2529B1OC%2528C%2529%2528C%2529C%2528C%2529%2528C%2529O1.png)
![Chemical structure of (3R)-3-fluoro-1-[2-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoyl]pyrrolidine - CSSB02526778519](/st/structure/200/14ebe321b175efb0a7dcf8ec528b429a/CC1%253DCC%253DC%2528C%253DC1C%2528%253DO%2529N1CC%255BC%2540%2540H%255D%2528F%2529C1%2529B1OC%2528C%2529%2528C%2529C%2528C%2529%2528C%2529O1.png)
